Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms

• Published in: Canadian Urological Association journal 2012-12, Vol.6 (6), p.E234
• Main Authors: Kuyumcuoglu, Ugur, Eryildirim, Bilal, Tuncer, Murat, Faydaci, Gokhan, Tarhan, Fatih, Ozgül, Aydin
• Format: Article
• Language: English
• Subjects: Complications and side effects; Stent (Surgery)
• ISSN: 1911-6470; 1920-1214
• DOI: 10.5489/cuaj.145

We investigated whether the frequency of lower urinary tract symptoms (LUTS) increased in patients in whom double-J stents were applied. We also evaluated several medical therapy protocols to treat symptoms related with ureteral stents. A total of 108 patients, in whom unilateral double-j stent was applied during ureteral stone treatment, were included. Before the double-J stent was applied, all patients completed storage components of the [quote]International Prostate Symptom Score[quote] (IPSSs), quality of life components of the IPSS (IPSS-QOL) and [quote]Overactive Bladder Questionnaire[quote] (OABq) forms and scores were calculated. After the procedure, cases were randomized into 5 groups, an antiinflammatory was given to Group 1, spasmolytic to Group 2, anticholinergic to Group 3 and [alpha]-blocker to Group 4. No additional drug was given to Group 5 as this control group. During the fourth week of the procedure, IPSSs, IPSS-QOL and OABq forms were again completed and scores were compared with the previous ones. When all the cases were evaluated, the IPSSs, IPSS-QOL and OABq scores of patients in whom the double-J stent was applied were statistically significantly higher the procedure. Compared to the control group, the cases where the double-J stent was applied showed a higher IPSSs, IPSS-QOL and OABq scores and none of the medical therapies could prevent this increase.